Postmenopausal women with a history of hormone therapy use have slower biological aging compared to those who never used the ...

Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...

Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...

Biological age vs chronological age was younger among postmenopausal female individuals who received hormone replacement therapy.

Studies have shown nonbiologic DMARD combination therapy results in a larger number of responses than methotrexate monotherapy does. Biologic response modifiers target molecules or immune cells ...

Decreased estrogen levels associated with menopause can accelerate biological aging, but hormone replacement therapy, which ...

Do you foresee IV and subQ route of administration always having a role moving forward? How do you see the treatment landscape changing?

This study investigates the therapeutic effectiveness and timeline for skin lesion resolution in plaque psoriasis patients treated with combined biologic agents compared to standard therapies. Methods ...

Becton, Dickinson and Company BDX, popularly known as BD, has announced the commercial release of the BD Neopak XtraFlow ...

An expert gastroenterologist dissects a study that analyzed patient experience with intravenous and subcutaneous biological therapies.

First-time biologic drug survival was not affected by the previous number of treatment series, the previous number of conventional treatments, or the time from first conventional therapy to biologic ...